FOX BIZ NEWS: France's Sanofi buys US hemophilia specialist Bioverativ

France's Sanofi buys US hemophilia specialist Bioverativ



France-based drugmaker Sanofi is buying U.S. hemophilia specialist Bioverativ for $11.6 billion in a deal that Sanofi says will boost its profile for fighting rare diseases.

via FOX BUSINESS NEWS http://ift.tt/2G5XPFd